Switzerland Zurich, eight o'clock in the morning.
In a secluded villa by Geneva Lake, lights were blazing. Seven people sat around the oval conference table—the representatives from European Commission Health Department, European Medicines Agency (EMA), French National Health Administration, German Federal Institute for Drugs and Medical Devices, along with three special observers: a medical advisor from a European royal family, a steward from an Italian industrial giant family, and Lillian Windsor herself.
This meeting had no official record, no minutes, and even the participants' phones were left in the shielding box outside. But the discussion's content could influence the direction of Europe's healthcare policy for the next decade.
